140 related articles for article (PubMed ID: 35716335)
1. Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database.
Balcerac A; Bihan K; Lebrun-Vignes B; Thabut D; Salem JE; Weiss N
Ann Intensive Care; 2022 Jun; 12(1):55. PubMed ID: 35716335
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced delusion: A comprehensive overview of the WHO pharmacovigilance database.
Balcerac A; Baldacci A; Romier A; Annette S; Lemarchand B; Bihan K; Bottemanne H
Psychiatry Res; 2023 Sep; 327():115365. PubMed ID: 37517106
[TBL] [Abstract][Full Text] [Related]
3. Drugs associated with posterior reversible encephalopathy syndrome, a worldwide signal detection study.
Balcerac A; Bihan K; Psimaras D; Lebrun-Vignes B; Salem JE; Weiss N
J Neurol; 2023 Feb; 270(2):975-985. PubMed ID: 36329183
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced antiphospholipid syndrome: Analysis of the WHO international database.
Gérardin C; Bihan K; Salem JE; Khachatryan H; Gerotziafas G; Fain O; Mekinian A
Autoimmun Rev; 2022 May; 21(5):103060. PubMed ID: 35114404
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin gene-related peptide-targeting drugs and Raynaud's phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database.
Gérard AO; Merino D; Van Obberghen EK; Rocher F; Destere A; Lantéri-Minet M; Drici MD
J Headache Pain; 2022 May; 23(1):53. PubMed ID: 35505285
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database.
Arnaud L; Mertz P; Gavand PE; Martin T; Chasset F; Tebacher-Alt M; Lambert A; Muller C; Sibilia J; Lebrun-Vignes B; Salem JE
Ann Rheum Dis; 2019 Apr; 78(4):504-508. PubMed ID: 30793701
[TBL] [Abstract][Full Text] [Related]
7. Drugs associated with systemic sclerosis: An updated list of suspected drugs using the WHO pharmacovigilance database.
Dumont A; Dolladille C; de Boysson H; Alexandre J; Nguyen A; Deshayes S; Aouba A
Autoimmun Rev; 2022 Sep; 21(9):103157. PubMed ID: 35902047
[TBL] [Abstract][Full Text] [Related]
8. Sipuleucel-T associated inflammatory cardiomyopathy: a case report and observations from a large pharmacovigilance database.
Moey MYY; Jiwani RA; Takeda K; Prenshaw K; Kreeger RW; Inzerillo J; Liles DK; Marcu CB; Lebrun-Vignes B; Morris DL; Ardhanari S; Salem JE
ESC Heart Fail; 2021 Aug; 8(4):3360-3368. PubMed ID: 33938158
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
[TBL] [Abstract][Full Text] [Related]
10. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced vitiligo: a case/non-case study in Vigibase
Anthony N; Bourneau-Martin D; Ghamrawi S; Lagarce L; Babin M; Briet M
Fundam Clin Pharmacol; 2020 Dec; 34(6):736-742. PubMed ID: 32246859
[TBL] [Abstract][Full Text] [Related]
12. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database.
Montastruc JL; Lafaurie M; de Canecaude C; Durrieu G; Sommet A; Montastruc F; Bagheri H
Br J Clin Pharmacol; 2021 Nov; 87(11):4334-4340. PubMed ID: 33837554
[TBL] [Abstract][Full Text] [Related]
13. IL-4/13 Blockade and sleep-related adverse drug reactions in over 37,000 Dupilumab reports from the World Health Organization Individual Case Safety reporting pharmacovigilance database (VigiBase™): a big data and machine learning analysis.
Alroobaea R; Rubaiee S; Hanbazazah AS; Jahrami H; Garbarino S; Damiani G; Wu J; Bragazzi NL
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):4074-4081. PubMed ID: 35731078
[TBL] [Abstract][Full Text] [Related]
14. Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database.
Alexandre J; Salem JE; Moslehi J; Sassier M; Ropert C; Cautela J; Thuny F; Ederhy S; Cohen A; Damaj G; Vilque JP; Plane AF; Legallois D; Champ-Rigot L; Milliez P; Funck-Brentano C; Dolladille C
Eur Heart J Cardiovasc Pharmacother; 2021 Jul; 7(4):312-320. PubMed ID: 32353110
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced disseminated intravascular coagulation: a pharmacovigilance study on World Health Organization's database.
Bonaldo G; Vaccheri A; Melis M; Motola D
J Thromb Thrombolysis; 2020 Nov; 50(4):763-771. PubMed ID: 32445062
[TBL] [Abstract][Full Text] [Related]
16. Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations.
Caster O; Aoki Y; Gattepaille LM; Grundmark B
Drug Saf; 2020 May; 43(5):479-487. PubMed ID: 32008183
[TBL] [Abstract][Full Text] [Related]
17. Associations between osteoporosis and drug exposure: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase®).
Batteux B; Bennis Y; Bodeau S; Masmoudi K; Hurtel-Lemaire AS; Kamel S; Gras-Champel V; Liabeuf S
Bone; 2021 Dec; 153():116137. PubMed ID: 34343739
[TBL] [Abstract][Full Text] [Related]
18. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years.
Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S
Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced IgA vasculitis in children and adults: Revisiting drug causality using a dual pharmacovigilance-based approach.
Rasmussen C; Tisseyre M; Garon-Czmil J; Atzenhoffer M; Guillevin L; Salem JE; Treluyer JM; Terrier B; Chouchana L
Autoimmun Rev; 2021 Jan; 20(1):102707. PubMed ID: 33197572
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase.
Ferrajolo C; Capuano A; Verhamme KM; Schuemie M; Rossi F; Stricker BH; Sturkenboom MC
Br J Clin Pharmacol; 2010 Nov; 70(5):721-8. PubMed ID: 21039766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
